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ABSTRACT 
Objective: Isolation and identification of Extended Spectrum Beta Lactamases from urinary isolates and to study their drug sensitivity pattern. 
Methods: The study was done on 200 patients with suspected urinary tract infection from Rajindra Hospital, Patiala. Urine samples were processed 
for significant bacteriuria. The antimicrobial susceptibility testing was done by Kirby-Bauer disc diffusion method as per the CLSI 
recommendations. ESBL production was tested by using the double-disk approximation test and the combination disk method. 
Results: Out of the total of 200 urine samples, there were 84 (42%) culture positive cases, out of which 78 (92.9%) were found to be gram negative 
bacilli. E. coli was found to be the commonest uropathogen (60.3%). The percentage of ESBL producers was 69.2%. Maximum number of ESBLs 
were found among E. coli isolates ie. 80.9%. E. coli was found to be sensitive to imipenem (97.9%) followed by nitrofurantoin (91.5%), amikacin 
(76.6%), piperacillin-tazobactam (68%) and gentamicin (53.2%). It was relatively resistant to ampicillin. Ciprofloxacin showed sensitivity of 29.8% 
in E. coli. 
Conclusion: E. coli and other isolates were more sensitive to impaired. Nitrofurantoin and piperacillin-tazobactam compared to the other 
antibiotics tested and therefore these may be the drugs of choice for treatment of infections that are caused by ESBLs. 
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INTRODUCTION 
Antimicrobial chemotherapy has been a leading cause for the 
dramatic rise of average life expectancy in the twentieth century. 
However, disease-causing microbes that have become resistant to 
antibiotic drug therapy are an increasing public health problem. 
There is one group of β-lactamases that is occasionally found in 
certain species of gram negative bacilli, usually Klebsiella 
pneumoniae and Escherichia coli. These enzymes are termed 
extended-spectrum β-lactamases (ESBLs) because they confer upon 
the bacteria the additional ability to hydrolyze the β-lactam rings of 
cefotaxime, ceftazidime or aztreonam [1].Microorganisms 
responsible for urinary tract infection (UTI) such as E. coli and 
Klebsiella spp. Have the ability to produce ESBLs in large quantities. 
These enzymes are plasmid borne and confer multiple drug 
resistance, making urinary tract infection difficult to treat [2]. 
MATERIALS AND METHODS 
The study was conducted on 200 urine samples received from 
clinically suspected patients of lower urinary tract infections coming 
from Rajindra hospital, Patiala. The samples were processed for 
significant bacteriuria in the department of Microbiology, 
Government Medical College, Patiala. Samples were tested for ESBL 
production by using the double-disk approximation test and the 
combination disk method which are recommended by CLSI. 
Antibiotic sensitivity testing 
The antimicrobial susceptibility testing was done by Kirby-Bauer 
disc diffusion method as per the CLSI recommendations by using 
various antibiotics (in μg) viz., ceftazidime(30), Cefepime(30), 
Cotrimoxazole (25), amikacin (30), gentamicin(10), ciprofloxacin 
(5),piperacillin-tazobactam (100/10), nitrofurantoin(300) and 
Imipenem (10). K. Pneumoniae ATCC 700603 was used as a control 
strain for positive ESBL production and E. coli 25922 was used as a 
negative control for ESBL production. 
Double-disk approximation test 
A lawn culture of test strain on Mueller Hinton Agar (Hi-Media, 
Mumbai) was exposed to a disc of later generation cephalosporin, 
eg. Cefotaxime (30μg) or ceftazidime (30μg) and a disc of amoxiclav 
(20μg amoxicillin/10μg clavulanic acid) was arranged in pairs. The 
discs were arranged so that the distance between them was 
approximately twice the radius of the inhibition zone produced by 
the later generation cephalosporin tested on its own. After overnight 
incubation, if the test strain had an extended spectrum β-lactamase, 
the inhibition zone around the cephalosporin disc was extended on 
the side nearest to the co-amoxiclav disc [3]. 
Combination disk method 
In this test, an overnight culture suspension of the test isolate which 
was adjusted to 0.5 McFarland’s standard was inoculated on the 
surface of a Mueller Hinton Agar plate. The cefotaxime (30μg) and 
cefotaxime-clavulanic acid (30μg/ 10μg) disks were placed 20 mm 
apart on the agar. Similarly, the ceftazidime (30μg) and ceftazidime-
clavulanic acid (30μg/ 10μg) disks were placed 20 mm apart. After 
incubating overnight at 37ºC, a ≥ 5-mm increase in the zone 
diameter for either antimicrobial agent which was tested in 
combination with clavulanic acid vs. Its zone when tested alone, was 
interpreted as positive for ESBL production [4]. 
  
Table 1: Percentage of various pathogens in culture positive 
cases 
Organisms No. of cases Percentage 
E. coli 47 60.3% 
Klebsiella pnuemoniae 16 20.5% 
P. aeruginosa 7 9% 
Proteus spp. 6 7.7% 
Enterobacter 2 2.5% 
Total 78 100% 
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RESULTS 
Out of total 200 urine samples, there were 84 (42%) culture positive 
cases, out of which 78 (92.9%) were found to be gram negative 
bacilli. E. coli was found to be the commonest uropathogen (60.3%) 
as shown in Table 1. 
E. coli was found to be sensitive to imipenem (97.9%) followed by 
nitrofurantoin (91.5%), amikacin (76.6%), piperacillin-tazobactam 
(68%) and gentamicin (53.2%). It was relatively resistant to 
ampicillin. Klebsiella pneumoniae was also found to be sensitive to 
imipenem (100%) followed by nitrofurantoin (93.8%), amikacin 
(75%), piperacillin-tazobactam (62.5%) and gentamicin (56.3%). 
Pseudomonas aeruginosa, Proteus spp.  
And Enterobacter showed 100% sensitivity to imipenem and 
nitrofurantoin. Ciprofloxacin showed sensitivity of 29.8% in E. coli, 
25% in Klebsiella pneumoniae, 42.9% in Pseudomonas aeruginosa, 
33.3% in Proteus spp. and 50% in Enterobacter as shown in Figure 1. 
The percentage of ESBL producers was 69.2%. Maximum ESBL 
producers were found among E. coli isolates ie. 80.9% followed by 
Klebsiella pneumoniae (75%). 
 
Fig. 1: Susceptibility pattern showing percentage of different 
bacterial isolates sensitive to various antimicrobial agents. 
 
Pseudomonas aeruginosa, Proteus spp. And Enterobacter were 
14.3%, 33.3% and 50% respectively as shown in Table 2. Double 
disk approximation test was less sensitive (74.07%) in detecting the 
ESBLs than the Combination disc method (100%). 
 
Table 2: Distribution of ESBL producers among different gram negative isolates 
Organism Double disk approximation test Combination disc method Chi square 
No. of cases %age No. of cases %age 
E. coli 30 63.8% 38 80.9% 1.68838 
(p<0.9) K. pnuemoniae 9 56.3% 12 75.0% 
P. aeruginosa 0 0% 1 14.3% 
Proteus spp. 1 16.7% 2 33.3% 
Enterobacter 0 0% 1 50% 
 
DISCUSSION 
E. coli (60.3%) was found to be the commonest organism 
responsible for urinary tract infections. Manjunath et al. showed 
66.8% isolation of E. coli [5]. E. coli was found to be sensitive to 
imipenem (97.9%) followed by nitrofurantoin (91.5%), amikacin 
(76.6%) and piperacillin-tazobactam (68%). Babypadmini et al. 
showed the susceptibility of ESBL producers to imipenem, 
nitrofurantoin and amikacin to be 100%, 89% and 86% respectively 
[2]. A study done by Umadevi et al showed 100% senisitivity to 
imipenem, 84% sensitivity to piperacillin-tazobactam and 68% 
sensitivity to amikacin [6]. The percentage of ESBL producers was 
69.2%. A study done by Mathur et al and Umadevi et al. showed 68% 
and 75% prevalence of ESBL producers respectively [6,7]. 
CONCLUSION 
Thus it can be concluded that the incidence of ESBL’s can minimized 
by judicious use of antibiotics and implementation of appropriate 
infection control measures to control the spread of these strains in 
the hospital. Moreover, our study concludes that E. coli and other 
isolates were more sensitive to imipenem, nitrofuranotin and 
piperacillin-tazobactam compared to the other antibiotics tested and 
therefore these may be the drugs of choice for treatment of 
infections that are caused by ESBLs.  
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